The Enterprise Value as of November 2025 (TTM) for Sinovac Biotech Ltd. (SVA) is -506209271.00

According to Sinovac Biotech Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -506209271.00. This represents a change of -81.17% compared to the average of -2688592180.01 of the last 4 quarters.

Sinovac Biotech Ltd. (SVA) Historical Enterprise Value (quarterly & annually)

How has SVA Enterprise Value performed in the past?

The mean historical Enterprise Value of Sinovac Biotech Ltd. over the last ten years is -1292660242.57. The current -506209271.00 Enterprise Value has changed 3.82% with respect to the historical average. Over the past ten years (40 quarters), SVA's Enterprise Value was at its highest in in the September 2020 quarter at 607.36M. The Enterprise Value was at its lowest in in the December 2021 quarter at -10821236768.90.

Sinovac Biotech Ltd. (SVA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sinovac Biotech Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sinovac Biotech Ltd. (SVA) Average Enterprise Value

How has SVA Enterprise Value performed in the past?

The current Enterprise Value of Sinovac Biotech Ltd. (SVA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sinovac Biotech Ltd. (SVA) Enterprise Value vs. Peers

How is SVA’s Enterprise Value compared to its peers?

Sinovac Biotech Ltd.’s Enterprise Value is less than iTeos Therapeutics, Inc. (245.99M), less than Invivyd, Inc. (212.37M), less than Sage Therapeutics, Inc. (488.88M), less than Revance Therapeutics, Inc. (805.89M), less than Big Cypress Acquisition Corp. (402.12M), less than Y-mAbs Therapeutics, Inc. (332.06M), less than Orchard Therapeutics plc (369.77M), less than Vigil Neuroscience, Inc. (346.93M), less than G1 Therapeutics, Inc. (402.64M), less than Checkpoint Therapeutics, Inc. (334.68M),

Build a custom stock screener for Sinovac Biotech Ltd. (SVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinovac Biotech Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sinovac Biotech Ltd. (SVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sinovac Biotech Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.